Bonderman David's Form 4 filing
Trevi Therapeutics, Inc. (TRVI) · filed Jul 6, 2022
- Accession no.
- 0001387131-22-007483
- Filed
- Jul 6, 2022, 5:00 PM ET
- Trade date
- Jul 1-5, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.44M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonderman DavidCIK 0000860866 | Other: Former 10% Owner |
| Coulter James GCIK 0001099776 | Other: Former 10% Owner |
| Winkelried JonCIK 0001366946 | Other: Former 10% Owner |
| TPG GP A, LLCCIK 0001903793 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2022 | Common Stock | SSaleDisposed | −436,431 | $2.86 | −$1,246,185.08 | 3,888,452 | Indirect | |
| Jul 5, 2022 | Common Stock | SSaleDisposed | −63,569 | $3.11 | −$197,826.73 | 3,824,883 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.